The U.S Patent and Trademark Office (USPTO) has recently published a set of guidelines for assessing the enablement requirement in utility applications and patents, pursuant to a ruling by the Supreme Court in Amgen Inc. et al. v. Sanofi et al. Legendary patent law attorney, Ryan Hagglund from Loeb & Loeb, provides his analysis detailing these guidelines. His highlights include how the guidelines can be universally applied across all fields of technology, interpreting the enablement principles outlined in the Supreme Court’s landmark 2023 Amgen v. Sanofi decision.
This new set of guidelines is targeted towards ascertaining compliance with the enablement requirement under Title 35 of the U.S. Code, Section 112. This is in response to the groundbreaking decision taken last year by the Supreme Court in the Amgen v. Sanofi case. Hagglund’s detailed review helps legal professionals appreciate and understand the full extent of the guidelines and their potential impact across various technological fields.
As legal practitioners are well aware, understanding and adhering to enablement requirements are key aspects of the patenting process, capable of influencing the outcome of patent applications significantly. Hence, the guidelines by the USPTO and Hagglund’s comprehensive analysis offer valuable insights for all legal professionals involved in intellectual property rights and patent law.